Eurand — Growing our portfolio of specialized gastrointestinal products for the U.S. market.
Eurand (NASDAQ: EURX) is a global specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies.
Product Licensing Opportunities
Eurand has a portfolio of existing products available in a variety of therapeutic categories.
Learn more about our
product development candidates
Pharmaceutical
technologies
for formulation
development
and life cycle management solutions
learn more + AMRIX® (Cyclobenzaprine Hydrochloride Extended-Release Capsules):
view all +AMRIX® is a registered trademark of Cephalon, Inc., or its affiliates
Zenpep™ is a registered trademark of Eurand Pharmaceuticals, Ltd.
